Justin Smith News
-
Fresenius SE failed to meet a goal of deciding whether to revive a 3.1-billion-euro ($3.9 billion) offer for German hospital operator Rhoen-Klinikum AG this month as both sides blamed each other for stalling the deal.
-
Smith & Nephew Plc rose the most in almost eight months in London trading after four U.K. newspapers reported that traders were speculating the maker of artificial knees and hips may receive a takeover offer.
-
Smith & Nephew Plc , Europe’s largest maker of knee and hip replacements, said it’s not in talks that may lead to a takeover or merger after the Daily Telegraph reported the company was about to start informal negotiations with Biomet Inc.
-
AstraZeneca Plc’s $1.26 billion purchase of Ardea Biosciences Inc., its biggest acquisition in five years, may be the first in a series of deals for the company as it tries to counter looming generic competition.
-
Russian businessman Mikhail Smirnov folded four eights, believing he was beaten by a straight flush, as the first $1 million buy-in charity tournament at the World Series of Poker began.
-
Novartis AG Chief Executive Officer Joseph Jimenez had worked in the pharmaceutical industry only four years before taking the helm of the Swiss drug giant in February 2010.
-
Sanofi-Aventis SA ’s talks to buy Genzyme Corp. are progressing, the French drugmaker said as it forecast profit will drop as much as 10 percent because of generic competition and the loss of flu vaccine sales.
-
AstraZeneca Plc, the U.K.’s second- biggest drugmaker, fell the most in five months after saying profit this year will decline as the company prepares to face generic competition to top-selling medicines.
-
Susan Choe , head of the online video-game startup Outspark Inc. , figured she’d found the right strategy when a family of four spent $35,000 for virtual goods on her site.
-
Glu Mobile Inc., the maker of “Contract Killer: Zombies” and “Gun Bros” games for smartphones, is offering potential buyers the fastest sales growth among U.S. mobile gaming competitors.
|
|
Most Popular on Bloomberg
|
| |
Rate this Page